ArticleJournal of cancer survivorship : research and practice2026
Perceptions of cognitive functioning among 10-year breast cancer survivors: a qualitative study.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore the context and experiences of breast cancer survivors living with perceived mild cognitive impairment (MCI) and the trajectory of these changes since diagnosis. Additionally, to explore the impact on psychosocial well-being, identity, functionality, and the strategies used to mitigate these difficulties. Lastly, to investigate the facilitators and barriers to the discussion of these concerns with the primary healthcare professionals.
methodsThis qualitative study used an analytic approach, through semi-structured interviews with 11 breast cancer survivors (for ≥ 10 years) who had cognitive complaints during or after cancer treatments, without formal diagnosis of MCI.
resultsThe participants reported impairments in memory, attention, processing speed and temporal orientation, that began during treatments and remained stable after their completion. Feelings of anger, embarrassment, frustration, and not seeing themselves as capable as before emerged from these difficulties. The fear of developing neurocognitive disorders, such as Alzheimer's disease, was reported as an important concern. Social isolation and work difficulties are among the most relevant implications for these women. Coping strategies (e.g., memory aids and compensation methods) are employed by these women. Lack of validation of cognitive concerns by the primary healthcare professionals was reported as a constraint in getting the help they aimed for.
conclusionThe study provides new in-depth data about perceived cognitive impairment, its multidomain impact, and strategies used to reduce its effects. IMPLICATIONS FOR CANCER SURVIVORS: These findings contribute to a better understanding of cognitive symptoms to create frameworks and interventions to formally improve survivors' quality of life.
Indexed as
Identifiers
42518107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.